UPDATE 1-Xenon Pharmaceuticals' acne drug fails mid-stage study

March 24 (Reuters) - Xenon Pharmaceuticals Inc said on Friday it would abandon its acne drug, after it failed to meet the main goal in a mid-stage study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.